INDIANAPOLIS , April 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2020 financial results on Thursday, April 23, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial
INDIANAPOLIS , April 7, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that due to the public health impact of the coronavirus outbreak, and to support the health and well-being of its employees, shareholders, and other meeting participants, the Board of Directors of Eli
Insulin savings available for people with commercial insurance and the uninsured by calling (833) 808-1234 INDIANAPOLIS , April 7, 2020 /PRNewswire/ -- In response to the crisis caused by COVID-19, Eli Lilly and Company (NYSE: LLY) is introducing the Lilly Insulin Value Program, allowing anyone
KENILWORTH, N.J. & NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)--Apr. 1, 2020-- Merck & Co., Inc., (NYSE: MRK), Pfizer Inc. (NYSE: PFE), and Eli Lilly and Company (NYSE: LLY) today announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
INDIANAPOLIS, April 1, 2020 – Governor Eric J. Holcomb and Mayor Joe Hogsett – and a coalition of statewide business and community partners including Eli Lilly and Company – announced a social distancing campaign to help flatten the curve for COVID-19 in Indiana.
INDIANAPOLIS and OXFORD, England , March 31, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in
-- Taltz is the first and only IL-17A antagonist approved to treat this population -- INDIANAPOLIS , March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for
INDIANAPOLIS , March 24, 2020 /PRNewswire/ -- To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly and Company (NYSE: LLY) today is providing updates related to insulin supply and affordability: As we announced on March 3 , Lilly does not
INDIANAPOLIS , March 23, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company will delay most new study starts and pause enrollment in most ongoing studies.
INDIANAPOLIS , March 22, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, March 23 , as a service to the community and in an effort to protect health care